BIOA B — BioArctic AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK27.12bn
- SEK24.98bn
- SEK2.00bn
Annual cashflow statement for BioArctic AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -140 | -17.4 | 253 | -229 | 1,259 |
| Depreciation | |||||
| Non-Cash Items | 5.23 | -55.4 | 2.46 | -68.1 | 24.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.96 | 27 | 47.2 | -30.4 | 135 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -140 | -31.6 | 310 | -316 | 1,431 |
| Capital Expenditures | -4.39 | -12.7 | -7.44 | -26.6 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.026 | -0.017 | -500 | 232 | -895 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.41 | -12.8 | -507 | 206 | -895 |
| Financing Cash Flow Items | — | — | -0.001 | -0.001 | 26.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7.39 | -2.81 | 14.1 | 5.69 | 26.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -152 | -43 | -194 | -98.6 | 528 |